{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T16:32:08Z","timestamp":1787243528617,"version":"build-2736575974"},"reference-count":70,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,7,5]],"date-time":"2023-07-05T00:00:00Z","timestamp":1688515200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>There is some evidence for an association between gut microbiota and nonalcoholic fatty liver disease (NAFLD), alcoholic liver disease (ALD), and viral hepatitis, but no studies have explored their causal relationship.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Instrumental variables of the gut microbiota (N = 13266) and gut microbiota-derived metabolites (N = 7824) were acquired, and a Mendelian randomization study was performed to explore their influence on NAFLD (1483 European cases and 17,781 European controls), ALD (2513 European cases and 332,951 European controls), and viral hepatitis risk (1971 European cases and 340,528 European controls). The main method for examining causality is inverse variance weighting (IVW).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      IVW results confirmed that\n                      <jats:italic>Anaerotruncus<\/jats:italic>\n                      (\n                      <jats:italic>p<\/jats:italic>\n                      = 0.0249),\n                      <jats:italic>Intestinimonas<\/jats:italic>\n                      (\n                      <jats:italic>p<\/jats:italic>\n                      = 0.0237),\n                      <jats:italic>Lachnoclostridium<\/jats:italic>\n                      (\n                      <jats:italic>p<\/jats:italic>\n                      = 0.0245),\n                      <jats:italic>Lachnospiraceae NC2004 group<\/jats:italic>\n                      (\n                      <jats:italic>p<\/jats:italic>\n                      = 0.0083),\n                      <jats:italic>Olsenella<\/jats:italic>\n                      (\n                      <jats:italic>p<\/jats:italic>\n                      = 0.0163), and\n                      <jats:italic>Peptococcus<\/jats:italic>\n                      (\n                      <jats:italic>p<\/jats:italic>\n                      = 0.0472) were protective factors for NAFLD, and\n                      <jats:italic>Ruminococcus 1<\/jats:italic>\n                      (\n                      <jats:italic>p<\/jats:italic>\n                      = 0.0120) was detrimental for NAFLD. The higher abundance of three genera,\n                      <jats:italic>Lachnospira<\/jats:italic>\n                      (\n                      <jats:italic>p<\/jats:italic>\n                      = 0.0388),\n                      <jats:italic>Desulfovibrio<\/jats:italic>\n                      (\n                      <jats:italic>p<\/jats:italic>\n                      = 0.0252), and\n                      <jats:italic>Ruminococcus torques group<\/jats:italic>\n                      (\n                      <jats:italic>p<\/jats:italic>\n                      = 0.0364), was correlated with a lower risk of ALD, while\n                      <jats:italic>Ruminococcaceae UCG 002<\/jats:italic>\n                      level was associated with a higher risk of ALD (\n                      <jats:italic>p<\/jats:italic>\n                      = 0.0371). The\n                      <jats:italic>Alistipes<\/jats:italic>\n                      (\n                      <jats:italic>p<\/jats:italic>\n                      = 0.0069) and\n                      <jats:italic>Ruminococcaceae NK4A214 group<\/jats:italic>\n                      (\n                      <jats:italic>p<\/jats:italic>\n                      = 0.0195) were related to a higher risk of viral hepatitis. Besides, alanine (\n                      <jats:italic>p<\/jats:italic>\n                      = 0.0076) and phenyllactate (\n                      <jats:italic>p<\/jats:italic>\n                      = 0.0100) were found to be negatively correlated with NAFLD, while stachydrine (O\n                      <jats:italic>p<\/jats:italic>\n                      = 0.0244) was found to be positively associated with NAFLD. The phenylacetate (\n                      <jats:italic>p<\/jats:italic>\n                      = 0.0353) and ursodeoxycholate (\n                      <jats:italic>p<\/jats:italic>\n                      = 0.0144) had a protective effect on ALD, while the threonate (\n                      <jats:italic>p<\/jats:italic>\n                      = 0.0370) exerted a detrimental influence on ALD. The IVW estimates of alanine (\n                      <jats:italic>p<\/jats:italic>\n                      = 0.0408) and cholate (\n                      <jats:italic>p<\/jats:italic>\n                      = 0.0293) showed their suggestive harmful effects against viral hepatitis, while threonate (\n                      <jats:italic>p<\/jats:italic>\n                      = 0.0401) displayed its suggestive protective effect against viral hepatitis.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>In conclusion, our research supported causal links between the gut microbiome and its metabolites and NAFLD, ALD, and viral hepatitis.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fendo.2023.1159148","type":"journal-article","created":{"date-parts":[[2023,7,5]],"date-time":"2023-07-05T13:51:50Z","timestamp":1688565110000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":45,"title":["Investigating causal associations among gut microbiota, metabolites, and liver diseases: a Mendelian randomization study"],"prefix":"10.3389","volume":"14","author":[{"given":"Lilong","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liuliu","family":"Zi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianrui","family":"Kuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunpeng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhendong","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongkai","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rongqiang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weixing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,7,5]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease-meta-analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-pathol-012615-044224","article-title":"Nonalcoholic fatty liver disease: Pathogenesis and disease spectrum","volume":"11","author":"Hardy","year":"2016","journal-title":"Annu Rev Pathol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1210\/endrev\/bnz009","article-title":"Nonalcoholic fatty liver disease in adults: Current concepts in etiology, outcomes, and management","volume":"41","author":"Marjot","year":"2020","journal-title":"Endocr Rev"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.951137","article-title":"Integration of transcriptomics, proteomics, and metabolomics data to reveal HER2-associated metabolic heterogeneity in gastric cancer with response to immunotherapy and neoadjuvant chemotherapy","volume":"13","author":"Yuan","year":"2022","journal-title":"Front Immunol"},{"key":"B5","article-title":"Alcoholic liver disease: Pathogenesis and current management","volume":"38","author":"Osna","year":"2017","journal-title":"Alcohol Res"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/s0168-8278(98)80339-5","article-title":"Disease progression and hepatocellular carcinogenesis in patients with chronic viral hepatitis: a prospective observation of 2215 patients","volume":"28","author":"Ikeda","year":"1998","journal-title":"J Hepatol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1038\/sj.embor.7400731","article-title":"The gut flora as a forgotten organ","volume":"7","author":"O'Hara","year":"2006","journal-title":"EMBO Rep"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.725390","article-title":"Molecular and cellular mediators of the gut-liver axis in the progression of liver diseases","volume":"8","author":"Bruneau","year":"2021","journal-title":"Front Med (Lausanne)"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms10051045","article-title":"Trust your gut: The association of gut microbiota and liver disease","volume":"10","author":"Manzoor","year":"2022","journal-title":"Microorganisms"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.3390\/ijms232012661","article-title":"Role of intestinal microbes in chronic liver diseases","volume":"23","author":"Xu","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1002\/hep.26093","article-title":"Characterization of gut microbiomes in nonalcoholic steatohepatitis (NASH) patients: a connection between endogenous alcohol and NASH","volume":"57","author":"Zhu","year":"2013","journal-title":"Hepatology"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1002\/hep.28356","article-title":"The severity of nonalcoholic fatty liver disease is associated with gut dysbiosis and shift in the metabolic function of the gut microbiota","volume":"63","author":"Boursier","year":"2016","journal-title":"Hepatology"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1002\/hep.28572","article-title":"Gut microbiota profiling of pediatric nonalcoholic fatty liver disease and obese patients unveiled by an integrated meta-omics-based approach","volume":"65","author":"Del Chierico","year":"2017","journal-title":"Hepatology"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgaa382","article-title":"Effect of gut microbiota and PNPLA3 rs738409 variant on nonalcoholic fatty liver disease (NAFLD) in obese youth","volume":"105","author":"Monga Kravetz","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.12938\/bmfh.18-032","article-title":"The role of gut microbiota in non-alcoholic fatty liver disease: pathways of mechanisms","volume":"38","author":"Jasirwan","year":"2019","journal-title":"Biosci Microbiota Food Health"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0062885","article-title":"Molecular characterization of the fecal microbiota in patients with nonalcoholic steatohepatitis\u2013a longitudinal study","volume":"8","author":"Wong","year":"2013","journal-title":"PloS One"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2017.17219","article-title":"Mendelian randomization","volume":"318","author":"Emdin","year":"2017","journal-title":"JAMA"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1006944","article-title":"Genetic epidemiology and mendelian randomization for informing disease therapeutics: Conceptual and methodological challenges","volume":"13","author":"Paternoster","year":"2017","journal-title":"PloS Genet"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4939-7868-7_13","article-title":"A primer in mendelian randomization methodology with a focus on utilizing published summary association data","volume":"1793","author":"Dimou","year":"2018","journal-title":"Methods Mol Biol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n2233","article-title":"Strengthening the reporting of observational studies in epidemiology using mendelian randomisation (STROBE-MR): explanation and elaboration","volume":"375","author":"Skrivankova","year":"2021","journal-title":"BMJ"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1038\/s41588-020-00763-1","article-title":"Large-scale association analyses identify host factors influencing human gut microbiome composition","volume":"53","author":"Kurilshikov","year":"2021","journal-title":"Nat Genet"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3233\/JAD-215411","article-title":"Investigating casual associations among gut microbiota, metabolites, and neurodegenerative diseases: A mendelian randomization study","volume":"87","author":"Ning","year":"2022","journal-title":"J Alzheimers Dis"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkx1089","article-title":"HMDB 4.0: the human metabolome database for 2018","volume":"46","author":"Wishart","year":"2018","journal-title":"Nucleic Acids Res"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2020.04.003","article-title":"Genome-wide association study of non-alcoholic fatty liver and steatohepatitis in a histologically characterised cohort","volume":"73","author":"Anstee","year":"2020","journal-title":"J Hepatol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"2022.03.03.22271360","DOI":"10.1101\/2022.03.03.22271360","article-title":"FinnGen: Unique genetic insights from combining isolated population and national health register data","author":"Kurki","year":"2022","journal-title":"medRxiv"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1038\/s41588-019-0350-x","article-title":"Causal relationships among the gut microbiome, short-chain fatty acids and metabolic diseases","volume":"51","author":"Sanna","year":"2019","journal-title":"Nat Genet"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1038\/nmeth.1974","article-title":"The 1000 genomes project: data management and community access","volume":"9","author":"Clarke","year":"2012","journal-title":"Nat Methods"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1002\/hep.32728","article-title":"The associations between modifiable risk factors and nonalcoholic fatty liver disease: A comprehensive mendelian randomization study","volume":"77","author":"Xie","year":"2023","journal-title":"Hepatology"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1002\/gepi.21965","article-title":"Consistent estimation in mendelian randomization with some invalid instruments using a weighted median estimator","volume":"40","author":"Bowden","year":"2016","journal-title":"Genet Epidemiol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dyv080","article-title":"Mendelian randomization with invalid instruments: effect estimation and bias detection through egger regression","volume":"44","author":"Bowden","year":"2015","journal-title":"Int J Epidemiol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1038\/s41588-018-0099-7","article-title":"Detection of widespread horizontal pleiotropy in causal relationships inferred from mendelian randomization between complex traits and diseases","volume":"50","author":"Verbanck","year":"2018","journal-title":"Nat Genet"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1007\/s00394-020-02369-z","article-title":"Habitual coffee intake and risk for nonalcoholic fatty liver disease: a two-sample mendelian randomization study","volume":"60","author":"Zhang","year":"2021","journal-title":"Eur J Nutr"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/j.joca.2021.08.003","article-title":"The causal role of gut microbiota in development of osteoarthritis","volume":"29","author":"Yu","year":"2021","journal-title":"Osteoarthritis Cartilage"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1038\/s41430-022-01074-w","article-title":"GWAS-associated bacteria and their metabolites appear to be causally related to the development of inflammatory bowel disease","volume":"76","author":"Zhuang","year":"2022","journal-title":"Eur J Clin Nutr"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.34408","article-title":"The MR-base platform supports systematic causal inference across the human phenome","volume":"7","author":"Hemani","year":"2018","journal-title":"Elife"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2020.583608","article-title":"Microbiota features associated with a high-Fat\/Low-Fiber diet in healthy adults","volume":"7","author":"Bailen","year":"2020","journal-title":"Front Nutr"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2018.01953","article-title":"Probiotic lactobacillus plantarum promotes intestinal barrier function by strengthening the epithelium and modulating gut microbiota","volume":"9","author":"Wang","year":"2018","journal-title":"Front Microbiol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1039\/c8ra01432a","article-title":"Association between metabolic profile and microbiomic changes in rats with functional dyspepsia","volume":"8","author":"Luo","year":"2018","journal-title":"RSC Adv"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms10062","article-title":"Production of butyrate from lysine and the amadori product fructoselysine by a human gut commensal","volume":"6","author":"Bui","year":"2015","journal-title":"Nat Commun"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1016\/j.foodres.2019.108939","article-title":"Ethanol extract of propolis prevents high-fat diet-induced insulin resistance and obesity in association with modulation of gut microbiota in mice","volume":"130","author":"Cai","year":"2020","journal-title":"Food Res Int"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2022.106348","article-title":"Microbiota diversity in nonalcoholic fatty liver disease and in drug-induced liver injury","volume":"182","author":"Rodriguez-Diaz","year":"2022","journal-title":"Pharmacol Res"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.3390\/nu13093240","article-title":"Adzuki bean alleviates obesity and insulin resistance induced by a high-fat diet and modulates gut microbiota in mice","volume":"13","author":"Zhao","year":"2021","journal-title":"Nutrients"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1039\/d0fo00334d","article-title":"Probiotic-fermented blueberry juice prevents obesity and hyperglycemia in high fat diet-fed mice in association with modulating the gut microbiota","volume":"11","author":"Zhong","year":"2020","journal-title":"Food Funct"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jafc.8b02979","article-title":"Pectin alleviates high fat (Lard) diet-induced nonalcoholic fatty liver disease in mice: Possible role of short-chain fatty acids and gut microbiota regulated by pectin","volume":"66","author":"Li","year":"2018","journal-title":"J Agric Food Chem"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.1027628","article-title":"Distinct common signatures of gut microbiota associated with damp-heat syndrome in patients with different chronic liver diseases","volume":"13","author":"Pan","year":"2022","journal-title":"Front Pharmacol"},{"key":"B46","doi-asserted-by":"publisher","first-page":"46","DOI":"10.38212\/2224-6614.3395","article-title":"Ulva prolifera polysaccharide exerts anti-obesity effects via upregulation of adiponectin expression and gut microbiota modulation in high-fat diet-fed C57BL\/6 mice","volume":"30","author":"Pung","year":"2022","journal-title":"J Food Drug Anal"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.00906","article-title":"The genus alistipes: Gut bacteria with emerging implications to inflammation, cancer, and mental health","volume":"11","author":"Parker","year":"2020","journal-title":"Front Immunol"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1099\/ijsem.0.000617","article-title":"Alistipes inops sp. nov. and coprobacter secundus sp. nov., isolated from human faeces","volume":"65","author":"Shkoporov","year":"2015","journal-title":"Int J Syst Evol Microbiol"},{"key":"B49","doi-asserted-by":"publisher","first-page":"6528","DOI":"10.1038\/ncomms7528","article-title":"Gut microbiome development along the colorectal adenoma-carcinoma sequence","volume":"6","author":"Feng","year":"2015","journal-title":"Nat Commun"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines10112676","article-title":"Exploring the association between gut and urine microbiota and prostatic disease including benign prostatic hyperplasia and prostate cancer using 16S rRNA sequencing","volume":"10","author":"Tsai","year":"2022","journal-title":"Biomedicines"},{"key":"B51","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1186\/s40168-018-0603-4","article-title":"A comparative study of the gut microbiota in immune-mediated inflammatory diseases-does a common dysbiosis exist","volume":"6","author":"Forbes","year":"2018","journal-title":"Microbiome"},{"key":"B52","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1093\/ecco-jcc\/jjw136","article-title":"Microbial factors associated with postoperative crohn's disease recurrence","volume":"11","author":"Wright","year":"2017","journal-title":"J Crohns Colitis"},{"key":"B53","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1080\/19490976.2019.1614394","article-title":"The association between gut microbiome and anthropometric measurements in bangladesh","volume":"11","author":"Osborne","year":"2020","journal-title":"Gut Microbes"},{"key":"B54","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1186\/s40168-018-0557-6","article-title":"Linking gut microbiota, metabolic syndrome and economic status based on a population-level analysis","volume":"6","author":"He","year":"2018","journal-title":"Microbiome"},{"key":"B55","doi-asserted-by":"publisher","first-page":"13424","DOI":"10.1038\/s41598-019-49462-w","article-title":"Discrepant gut microbiota markers for the classification of obesity-related metabolic abnormalities","volume":"9","author":"Zeng","year":"2019","journal-title":"Sci Rep"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2018-316106","article-title":"Population-level analysis of blastocystis subtype prevalence and variation in the human gut microbiota","volume":"68","author":"Tito","year":"2019","journal-title":"Gut"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1038\/nature12506","article-title":"Richness of human gut microbiome correlates with metabolic markers","volume":"500","author":"Le Chatelier","year":"2013","journal-title":"Nature"},{"key":"B58","doi-asserted-by":"publisher","first-page":"16088","DOI":"10.1038\/nmicrobiol.2016.88","article-title":"Species-function relationships shape ecological properties of the human gut microbiome","volume":"1","author":"Vieira-Silva","year":"2016","journal-title":"Nat Microbiol"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1016\/j.tim.2016.02.015","article-title":"Oscillospira: a central, enigmatic component of the human gut microbiota","volume":"24","author":"Konikoff","year":"2016","journal-title":"Trends Microbiol"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1038\/ismej.2015.11","article-title":"A phylo-functional core of gut microbiota in healthy young chinese cohorts across lifestyles, geography and ethnicities","volume":"9","author":"Zhang","year":"2015","journal-title":"ISME J"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1038\/s41564-018-0337-x","article-title":"The neuroactive potential of the human gut microbiota in quality of life and depression","volume":"4","author":"Valles-Colomer","year":"2019","journal-title":"Nat Microbiol"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1017\/S0007114519000680","article-title":"Gut prevotella as a possible biomarker of diet and its eubiotic versus dysbiotic roles: a comprehensive literature review","volume":"122","author":"Precup","year":"2019","journal-title":"Br J Nutr"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1128\/AEM.68.10.5186-5190.2002","article-title":"Acetate utilization and butyryl coenzyme a (CoA):acetate-CoA transferase in butyrate-producing bacteria from the human large intestine","volume":"68","author":"Duncan","year":"2002","journal-title":"Appl Environ Microbiol"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.3390\/nu10080988","article-title":"The potential of gut commensals in reinforcing intestinal barrier function and alleviating inflammation","volume":"10","author":"Hiippala","year":"2018","journal-title":"Nutrients"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1111\/apa.14644","article-title":"The gut microbiota of hand, foot and mouth disease patients demonstrates down-regulated butyrate-producing bacteria and up-regulated inflammation-inducing bacteria","volume":"108","author":"Li","year":"2019","journal-title":"Acta Paediatr"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1038\/nm.4236","article-title":"A purified membrane protein from akkermansia muciniphila or the pasteurized bacterium improves metabolism in obese and diabetic mice","volume":"23","author":"Plovier","year":"2017","journal-title":"Nat Med"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2020.1736974","article-title":"Probiotic-directed modulation of gut microbiota is basal microbiome dependent","volume":"12","author":"Hou","year":"2020","journal-title":"Gut Microbes"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.12033","article-title":"Desulfovibrio is not always associated with adverse health effects in the guangdong gut microbiome project","volume":"9","author":"Chen","year":"2021","journal-title":"PeerJ"},{"key":"B69","doi-asserted-by":"publisher","first-page":"4736","DOI":"10.1038\/s41598-018-38216-9","article-title":"Metabolic phenotypes and the gut microbiota in response to dietary resistant starch type 2 in normal-weight subjects: a randomized crossover trial","volume":"9","author":"Zhang","year":"2019","journal-title":"Sci Rep"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2021.798052","article-title":"Supplementation with chinese medicinal plant extracts from lonicera hypoglauca and scutellaria baicalensis mitigates colonic inflammation by regulating oxidative stress and gut microbiota in a colitis mouse model","volume":"11","author":"Wan","year":"2021","journal-title":"Front Cell Infect Microbiol"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2023.1159148\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,5]],"date-time":"2023-07-05T13:52:03Z","timestamp":1688565123000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2023.1159148\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,5]]},"references-count":70,"alternative-id":["10.3389\/fendo.2023.1159148"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2023.1159148","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,5]]},"article-number":"1159148"}}